Pay in 4 interest-free payments of $6.53 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
You can read more about the proposed mechanism of action and research on both peptides here
The reality is more complicated
Real-world weight loss expectations Conservative estimate (most people): 8-10% body weight loss at 2.4mg weekly Example: 220 lbs 198-202 lbs (18-22 lbs lost) 68 weeks to maximum Realistic, achievable Average responder: 10-12% body weight loss Example: 220 lbs 194-198 lbs (22-26 lbs lost) Typical trial results Most common outcome Excellent responder: 12-15% body weight loss Example: 220 lbs 187-194 lbs (26-33 lbs lost) 20-30% of users Good adherence + lifestyle With combination (CagriSema): 15-25% body weight loss Example: 220 lbs 165-187 lbs (33-55 lbs lost) Superior results Requires both peptides Factors affecting results: Starting weight (higher = more absolute pounds) Diet adherence (protein intake critical) Exercise (resistance training preserves muscle) Sleep quality (affects metabolism) Stress levels (cortisol impacts weight) Medication adherence Access personalized protocols at SeekPeptides - our AI advisor helps optimize your cagrilintide weight loss journey based on your specific situation
[PMID: 8516245] PubMed record related to this compound for laboratory literature review
A synthetic cell-penetrating peptide engineered from a fragment of the FOXO4 protein, also known as Proxofim, FOXO4-DRI is studied as a senolytic that clears worn-out cells
Getting the dosage right is important for health benefits
US$ 20.08
US$ 27.07
US$ 21.89
